Patents by Inventor Ioanna Andreou

Ioanna Andreou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190194718
    Abstract: The present invention is directed to novel methods, kits and uses to be employed for the generation of tagged DNA fragments of a target DNA and nucleic acid molecules associated therewith
    Type: Application
    Filed: December 11, 2014
    Publication date: June 27, 2019
    Inventors: Ioanna Andreou, Nan Fang, Dirk Loeffert, Annika Piotrowski
  • Patent number: 8859749
    Abstract: The present invention refers to a double-stranded siRNA molecule comprising a sense Strand and an antisense Strand which is essentially complementary to the sense Strand, each of the sense and the antisense Strands comprising at least 17 nucleotides (nt), the siRNA further comprising at least one overhang at the 5? and/or 3? end, wherein the overhang residue or overhang residues are chemically modified and selected independently from each other from the group consisting of: (a) 2?-deoxy modified nucleotides; (b) 2?-methoxy modified nucleotides; (c) two nucleosides linked by a 3? to 5? or 2? to 5? formacetal linkage; (d) nucleotides modified at the 2?-position by a —O—CH2—O—(CH2)2—OH group; and (e) nucleotides comprising in the 3?-position a —CH2—O—(CH2)7—CH3 group.
    Type: Grant
    Filed: March 8, 2006
    Date of Patent: October 14, 2014
    Assignee: QIAGEN GmbH
    Inventors: Ioanna Andreou, Stefan Pitsch, Evelyne Muller, Luc Reymond
  • Publication number: 20100227406
    Abstract: The present invention relates to a process for cell purification, for cell recovery from cultures and for the transfection of the cells under especially gentle conditions, where this process can additionally be coupled with subsequent isolation and purification of polynucleotides from the optionally transfected cells, and a kit and a device for the implementation of this process.
    Type: Application
    Filed: May 21, 2008
    Publication date: September 9, 2010
    Inventors: Ioanna Andreou, Ralf Himmelreich, Andrea Janosch
  • Publication number: 20090317906
    Abstract: The present invention generally relates to gene silencing using sense DNA (sDNA)-antisense RNA (aRNA) hybrids wherein the sense DNA strand is coupled to a peptide which facilitates the uptake of the hybrid into cells.
    Type: Application
    Filed: November 11, 2005
    Publication date: December 24, 2009
    Applicant: QIAGEN GMBH
    Inventors: Martin Weber, Ioanna Andreou, Nicole Bezay
  • Publication number: 20090306177
    Abstract: Double-stranded short interfering ribonucleic acid (siRNA) are modified to reduce or eliminate their immunostimulatory effect without significantly affecting their gene silencing effect. Modified siRNA include one or more 2? sugar modifications and, optionally, internucleotide linkages on the sense strand. Compositions containing the modified siRNA and methods of making and using the modified siRNA are disclosed. New and previously characterized siRNA can be synthesized to incorporate modifications according to the invention.
    Type: Application
    Filed: September 15, 2006
    Publication date: December 10, 2009
    Applicants: Coley Pharmaceutical GmbH, Qiagen GmbH
    Inventors: Eugen Uhlmann, Marion Jurk, Joerg Vollmer, Christian Schetter, Martin Weber, Ioanna Andreou, Stefan Pitsch
  • Publication number: 20090197332
    Abstract: The present invention refers to a double-stranded siRNA molecule comprising a sense Strand and an antisense Strand which is essentially complementary to the sense Strand, each of the sense and the antisense Strands comprising at least 17 nucleotides (nt), the siRNA further comprising at least one overhang at the 5? and/or 3? end, wherein the overhang residue or overhang residues are chemically modified and selected independently from each other from the group consisting of: (a) 2?-deoxy modified nucleotides; (b) 2?-methoxy modified nucleotides; (c) two nucleosides linked by a 3? to 5? or 2? to 5? formacetal linkage; (d) nucleotides modified at the 2?-position by a -0-CH2—O—(CH2)2—OH group; and (e) nucleotides comprising in the 3?-position a —CH2—O—(CH2)7—CH3 group.
    Type: Application
    Filed: March 8, 2006
    Publication date: August 6, 2009
    Inventors: Ioanna Andreou, Stefan Pitsch, Evelyne Muller, Luc Reymond